Resonant Medical
Montréal
About Resonant Medical
Resonant Medical develops, manufactures, and commercializes 3D ultrasound image-guided adaptive radiotherapy products. Its products include Clarity Breast System, an IGRT solution for precise non-ionizing guidance for boost and conformal breast treatments; Clarity Prostate System, an IGRT solution for precise non-invasive guidance for prostate treatments; and Multi-Anatomy System, an IGRT solution for precise non-invasive guidance for soft tissue anatomy IGRT treatments, such as gyne and bladder. Resonant Medical serves physicians, physicists, therapists, and administrators. Fred Francis, Anthony Falco, Luc Sirois, and François Perraton founded it in 2000, with its headquarters in Montreal in Canada, and Elekta acquired it as of May 31, 2010.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $24.0M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2010)
- Website: resonantmedical.com
- Phone: 514-985-2442
Industries & Categories
Alternative Medicine, Biotechnology, Health Care, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/resonant-medical-2723219 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.